Literature DB >> 3837853

Deregulation of c-myc gene expression in human colon carcinoma is not accompanied by amplification or rearrangement of the gene.

M D Erisman, P G Rothberg, R E Diehl, C C Morse, J M Spandorfer, S M Astrin.   

Abstract

The structure and expression of the c-myc oncogene were examined in 29 primary human colon adenocarcinomas. Dot blot hybridization of total RNA showed that 21 tumors (72%) had considerably elevated expression of c-myc (5- to 40-fold) relative to normal colonic mucosa. These data were corroborated by Northern blots of polyadenylated RNA, which showed a 2.3-kilobase transcript. Southern analysis of the c-myc locus in these tumors indicated the absence of amplification or DNA rearrangement in a 35-kilobase region encompassing the gene. In a parallel study, elevated expression of c-myc without amplification or DNA rearrangement was also observed in three of six colon carcinoma cell lines examined; in addition, unlike a normal colon cell line control, these three cell lines exhibited constitutive, high-level expression of the gene during their growth in cultures. These results indicate that elevated expression of the c-myc oncogene occurs frequently in primary human colon carcinomas and that the mechanism involved in the regulation of c-myc expression is altered in tumor-derived cell lines.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3837853      PMCID: PMC366914          DOI: 10.1128/mcb.5.8.1969-1976.1985

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  51 in total

1.  Relationship of c-myc expression to differentiation and proliferation of HL-60 cells.

Authors:  J Filmus; R N Buick
Journal:  Cancer Res       Date:  1985-02       Impact factor: 12.701

2.  Functional role for c-myc in mitogenic response to platelet-derived growth factor.

Authors:  H A Armelin; M C Armelin; K Kelly; T Stewart; P Leder; B H Cochran; C D Stiles
Journal:  Nature       Date:  1984 Aug 23-29       Impact factor: 49.962

3.  Regulated transcription of c-Ki-ras and c-myc during compensatory growth of rat liver.

Authors:  M Goyette; C J Petropoulos; P R Shank; N Fausto
Journal:  Mol Cell Biol       Date:  1984-08       Impact factor: 4.272

4.  Translocated c-myc oncogene of Burkitt lymphoma is transcribed in plasma cells and repressed in lymphoblastoid cells.

Authors:  C M Croce; J Erikson; A ar-Rushdi; D Aden; K Nishikura
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

5.  Transcriptional activation of the translocated c-myc oncogene in mouse plasmacytomas: similar RNA levels in tumor and proliferating normal cells.

Authors:  E J Keath; A Kelekar; M D Cole
Journal:  Cell       Date:  1984-06       Impact factor: 41.582

6.  Spatial and temporal pattern of cellular myc oncogene expression in developing human placenta: implications for embryonic cell proliferation.

Authors:  S Pfeifer-Ohlsson; A S Goustin; J Rydnert; T Wahlström; L Bjersing; D Stehelin; R Ohlsson
Journal:  Cell       Date:  1984-09       Impact factor: 41.582

7.  Expression of c-myc changes during differentiation of mouse erythroleukaemia cells.

Authors:  H M Lachman; A I Skoultchi
Journal:  Nature       Date:  1984 Aug 16-22       Impact factor: 49.962

8.  Suppression of the normal mouse c-myc oncogene in human lymphoma cells.

Authors:  S Feo; A ar-Rushdi; K Huebner; J Finan; P C Nowell; B Clarkson; C M Croce
Journal:  Nature       Date:  1985 Feb 7-13       Impact factor: 49.962

9.  C-myc transcript is induced in rat liver at a very early stage of regeneration or by cycloheximide treatment.

Authors:  R Makino; K Hayashi; T Sugimura
Journal:  Nature       Date:  1984 Aug 23-29       Impact factor: 49.962

10.  Expression of myb, myc and fos proto-oncogenes during the differentiation of a murine myeloid leukaemia.

Authors:  T J Gonda; D Metcalf
Journal:  Nature       Date:  1984 Jul 19-25       Impact factor: 49.962

View more
  86 in total

1.  Distinct cellular factors regulate the c-myb promoter through its E2F element.

Authors:  M R Campanero; M Armstrong; E Flemington
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

Review 2.  Genetics of colon cancer.

Authors:  D J Ahnen
Journal:  West J Med       Date:  1991-06

Review 3.  The role of viral and bacterial pathogens in gastrointestinal cancer.

Authors:  Michael Selgrad; Peter Malfertheiner; Lucia Fini; Ajay Goel; C Richard Boland; Luigi Ricciardiello
Journal:  J Cell Physiol       Date:  2008-08       Impact factor: 6.384

Review 4.  c-Myc target genes involved in cell growth, apoptosis, and metabolism.

Authors:  C V Dang
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

5.  Activation of the pp60c-src protein kinase is an early event in colonic carcinogenesis.

Authors:  C A Cartwright; A I Meisler; W Eckhart
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

6.  c-myc overexpression is a tumor-specific phenomenon in a subset of human colorectal carcinomas.

Authors:  A Viel; R Maestro; G Toffoli; G Grion; M Boiocchi
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

7.  Expression of the ErbA-beta class of thyroid hormone receptors is selectively lost in human colon carcinoma.

Authors:  S Markowitz; M Haut; T Stellato; C Gerbic; K Molkentin
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

8.  Identification of a colon mucosa gene that is down-regulated in colon adenomas and adenocarcinomas.

Authors:  C W Schweinfest; K W Henderson; S Suster; N Kondoh; T S Papas
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

9.  Mutations in the G-quadruplex silencer element and their relationship to c-MYC overexpression, NM23 repression, and therapeutic rescue.

Authors:  Cory L Grand; Tiffanie J Powell; Raymond B Nagle; David J Bearss; Denise Tye; Mary Gleason-Guzman; Laurence H Hurley
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-12       Impact factor: 11.205

10.  Integrin alpha6Bbeta4 inhibits colon cancer cell proliferation and c-Myc activity.

Authors:  Anders Bondo Dydensborg; Inga C Teller; Jean-François Groulx; Nuria Basora; Fréderic Paré; Elizabeth Herring; Rémy Gauthier; Dominique Jean; Jean-François Beaulieu
Journal:  BMC Cancer       Date:  2009-07-09       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.